Precigen (PGEN) News Today $1.90 -0.08 (-3.81%) As of 02:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Precigen (NASDAQ:PGEN) Hits New 1-Year High - Here's WhyPrecigen (NASDAQ:PGEN) Hits New 52-Week High - Should You Buy?February 20 at 7:37 AM | marketbeat.comPrecigen (NASDAQ:PGEN) Trading 8.4% Higher - Here's What HappenedPrecigen (NASDAQ:PGEN) Shares Up 8.4% - Should You Buy?February 19 at 10:35 PM | marketbeat.comAnalysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $7.00Shares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five brokerages that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and four have given a buy recommeFebruary 17, 2025 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by AnalystsPrecigen, Inc. (NASDAQ:PGEN - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the five analysts that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation and four have issued a bFebruary 14, 2025 | marketbeat.comPGEN Stock Soars to 52-Week High, Reaching $1.93 Amid GrowthFebruary 13, 2025 | msn.comPrecigen (NASDAQ:PGEN) Sets New 52-Week High - Still a Buy?Precigen (NASDAQ:PGEN) Sets New 52-Week High - Here's What HappenedFebruary 12, 2025 | marketbeat.comPrecigen: Successful Proof Of Platform, But Cash Worries RemainFebruary 10, 2025 | seekingalpha.comPrecigen (NASDAQ:PGEN) Stock Price Up 7.8% - Time to Buy?Precigen (NASDAQ:PGEN) Trading 7.8% Higher - Should You Buy?February 7, 2025 | marketbeat.comIridian Asset Management LLC CT Purchases 1,465,962 Shares of Precigen, Inc. (NASDAQ:PGEN)Iridian Asset Management LLC CT increased its position in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 38.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,241,922 shares of the biotechnology company's stock after purchasing an addiFebruary 7, 2025 | marketbeat.comJPMorgan Chase & Co. Decreases Stake in Precigen, Inc. (NASDAQ:PGEN)JPMorgan Chase & Co. decreased its holdings in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 18.0% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 884,275 shares of the biotechnology company's stock after selling 194,514 shares during the quJanuary 27, 2025 | marketbeat.comFY2024 EPS Estimates for Precigen Lifted by HC WainwrightPrecigen, Inc. (NASDAQ:PGEN - Free Report) - HC Wainwright upped their FY2024 EPS estimates for shares of Precigen in a research note issued on Thursday, January 23rd. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will earn ($0.30) per share for the year, up from tJanuary 27, 2025 | marketbeat.comPrecigen's SWOT analysis: biotech firm's stock poised for growth with PRGN-2012January 24, 2025 | msn.comLexAurum Advisors LLC Increases Stock Position in Precigen, Inc. (NASDAQ:PGEN)LexAurum Advisors LLC grew its position in shares of Precigen, Inc. (NASDAQ:PGEN - Free Report) by 151.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 691,544 shares of the biotechnology company's stock after purchasing an additional 41January 24, 2025 | marketbeat.comFY2026 EPS Estimates for Precigen Decreased by HC WainwrightPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Research analysts at HC Wainwright cut their FY2026 EPS estimates for shares of Precigen in a note issued to investors on Thursday, January 23rd. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology company will earn ($0.01) per shJanuary 24, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Precigen (NASDAQ:PGEN)HC Wainwright reiterated a "buy" rating and issued a $6.00 price target (up from $4.00) on shares of Precigen in a research report on Thursday.January 24, 2025 | marketbeat.comPrecigen price target raised to $6 from $4 at H.C. WainwrightJanuary 23, 2025 | markets.businessinsider.comInvestors Purchase High Volume of Call Options on Precigen (NASDAQ:PGEN)Precigen, Inc. (NASDAQ:PGEN - Get Free Report) was the target of some unusual options trading activity on Thursday. Investors acquired 11,169 call options on the stock. This is an increase of approximately 1,645% compared to the average volume of 640 call options.January 23, 2025 | marketbeat.comPrecigen's (PGEN) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $6.00 price target (up from $4.00) on shares of Precigen in a report on Thursday.January 23, 2025 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the five research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation and four have issuedJanuary 20, 2025 | marketbeat.comPrecigen shares rebound above Nasdaq minimum bid priceJanuary 16, 2025 | msn.comShould You Invest in Precigen (PGEN)?January 16, 2025 | msn.comPrecigen’s Strategic Advancements and Pipeline Developments Drive Buy RatingJanuary 14, 2025 | markets.businessinsider.comPrecigen (NASDAQ:PGEN) Receives Market Outperform Rating from JMP SecuritiesJMP Securities reissued a "market outperform" rating and issued a $5.00 price target on shares of Precigen in a report on Tuesday.January 14, 2025 | marketbeat.comPrecigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 13, 2025 | prnewswire.comPrecigen to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | prnewswire.comStock Traders Purchase High Volume of Precigen Call Options (NASDAQ:PGEN)Precigen, Inc. (NASDAQ:PGEN - Get Free Report) was the recipient of some unusual options trading on Thursday. Stock traders bought 11,343 call options on the stock. This represents an increase of approximately 3,908% compared to the average daily volume of 283 call options.January 2, 2025 | marketbeat.comPrecigen Completes Regulatory Filing For Approval Of Gene Therapy To Treat Respiratory Papillomatosis: Retail Sentiment Surges Amid Stock RallyDecember 31, 2024 | msn.comPrecigen’s Strategic Advances and Financial Strength Boost Market Position for PRGN-2012December 30, 2024 | markets.businessinsider.comPrecigen Announces Submission Of BLA For PRGN-2012 - Quick FactsDecember 30, 2024 | markets.businessinsider.comPrecigen price target lowered to $5 from $7 at JMP SecuritiesDecember 30, 2024 | markets.businessinsider.comPrecigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory PapillomatosisDecember 30, 2024 | prnewswire.comPrecigen announces $79M private placement of Convertible Preferred StockDecember 27, 2024 | markets.businessinsider.comPrecigen Announces $79.0 Million Private Placement Offering of Convertible Preferred StockDecember 27, 2024 | prnewswire.comPrecigen, Inc. (NASDAQ:PGEN) Receives Average Rating of "Moderate Buy" from AnalystsShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the five analysts that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating and four have assigned a buy rDecember 26, 2024 | marketbeat.comInovio Pharmaceuticals: The Dangerous Allure Of A Falling KnifeDecember 15, 2024 | seekingalpha.comPrecigen, Inc. (NASDAQ:PGEN) Given Average Rating of "Moderate Buy" by BrokeragesShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have earned a consensus rating of "Moderate Buy" from the five analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and four have given a buy rating to the comDecember 1, 2024 | marketbeat.comPrecigen's SWOT analysis: biotech stock focuses on RRP treatmentNovember 27, 2024 | uk.investing.comPrecigen Reports Q3 2024 Financial ResultsNovember 22, 2024 | tipranks.comPrecigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86%November 20, 2024 | finance.yahoo.comHC Wainwright Reduces Earnings Estimates for PrecigenPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Equities research analysts at HC Wainwright reduced their FY2026 earnings estimates for shares of Precigen in a research report issued on Friday, November 15th. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology company will postNovember 18, 2024 | marketbeat.comPrecigen, Inc. (PGEN) Stock Price, News, Quote & History - Yahoo FinanceNovember 17, 2024 | finance.yahoo.comPrecigen’s Promising Developments and Strategic Focus Drive Buy RatingNovember 15, 2024 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Precigen (PGEN)November 15, 2024 | markets.businessinsider.comHC Wainwright Reiterates Buy Rating for Precigen (NASDAQ:PGEN)HC Wainwright restated a "buy" rating and issued a $4.00 price objective on shares of Precigen in a report on Friday.November 15, 2024 | marketbeat.comPrecigen, Inc.: Precigen Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 15, 2024 | finanznachrichten.dePrecigen’s Strategic Advancements and FDA Alignment Bolster Buy RatingNovember 15, 2024 | markets.businessinsider.comPrecigen Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 14, 2024 | prnewswire.comPrecigen (NASDAQ:PGEN) Shares Cross Below 200 Day Moving Average - Here's WhyPrecigen (NASDAQ:PGEN) Share Price Crosses Below Two Hundred Day Moving Average - Here's WhyNovember 14, 2024 | marketbeat.comPrecigen to Participate in the Stifel 2024 Healthcare ConferenceNovember 12, 2024 | finance.yahoo.comPrecigen to Participate in the Stifel 2024 Healthcare ConferenceNovember 12, 2024 | prnewswire.com Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address PGEN Media Mentions By Week PGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼0.870.60▲Average Medical News Sentiment PGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼32▲PGEN Articles Average Week Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MESO News Today CNTA News Today BHC News Today HRMY News Today CGON News Today TARS News Today JANX News Today AGIO News Today NAMS News Today IDYA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PGEN Stock Alerts